Acumen Pharmaceuticals, Inc. (ABOS) › Shareholders' EquityAcumen Pharmaceuticals, Inc. (ABOS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$11.42M2020: -$18.59M2021: $225.18M2022: $188.78M2023: $266.97M2024: $181.82M2025: $70.43M$70.43M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$70.43M-61.3%2024$181.82M-31.9%2023$266.97M+41.4%2022$188.78M-16.2%2021$225.18M+1311.2%2020-$18.59M-62.8%2019-$11.42M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share